Jon Florholmen

3.4k total citations
60 papers, 2.0k citations indexed

About

Jon Florholmen is a scholar working on Genetics, Immunology and Epidemiology. According to data from OpenAlex, Jon Florholmen has authored 60 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Genetics, 28 papers in Immunology and 21 papers in Epidemiology. Recurrent topics in Jon Florholmen's work include Inflammatory Bowel Disease (34 papers), Microscopic Colitis (17 papers) and IL-33, ST2, and ILC Pathways (16 papers). Jon Florholmen is often cited by papers focused on Inflammatory Bowel Disease (34 papers), Microscopic Colitis (17 papers) and IL-33, ST2, and ILC Pathways (16 papers). Jon Florholmen collaborates with scholars based in Norway, China and Denmark. Jon Florholmen's co-authors include Rasmus Goll, Guanglin Cui, Trine Olsen, Ingrid Christiansen, Aping Yuan, Barthold Vonen, Jan‐Magnus Kvamme, Anne Husebekk, Ruth H. Paulssen and Eyvind J. Paulssen and has published in prestigious journals such as PLoS ONE, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Jon Florholmen

60 papers receiving 2.0k citations

Peers

Jon Florholmen
Wu Zhen Dong United Kingdom
Xavier Tréton France
Marjorie Argollo Italy
Murat Törüner Türkiye
Fabrizio Bossa Italy
Jean Frédéric Colombel France
Jan Däbritz Germany
Steven M. Cohn United States
Colette Deslandres Canada
Jakob Hendel Denmark
Wu Zhen Dong United Kingdom
Jon Florholmen
Citations per year, relative to Jon Florholmen Jon Florholmen (= 1×) peers Wu Zhen Dong

Countries citing papers authored by Jon Florholmen

Since Specialization
Citations

This map shows the geographic impact of Jon Florholmen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Florholmen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Florholmen more than expected).

Fields of papers citing papers by Jon Florholmen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Florholmen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Florholmen. The network helps show where Jon Florholmen may publish in the future.

Co-authorship network of co-authors of Jon Florholmen

This figure shows the co-authorship network connecting the top 25 collaborators of Jon Florholmen. A scholar is included among the top collaborators of Jon Florholmen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Florholmen. Jon Florholmen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sørbye, Sveinung Wergeland, et al.. (2021). Real-life evaluation of histologic scores for Ulcerative Colitis in remission. PLoS ONE. 16(3). e0248224–e0248224. 7 indexed citations
2.
Johnsen, Kay-Martin, Sveinung Wergeland Sørbye, Tor Inge Tønnessen, et al.. (2020). Clinical characterization of Helicobacter pylori infected patients 15 years after unsuccessful eradication. PLoS ONE. 15(9). e0238944–e0238944. 3 indexed citations
3.
Cui, Guanglin, Aping Yuan, Li Zhu, Jon Florholmen, & Rasmus Goll. (2017). Increased expression of interleukin-21 along colorectal adenoma-carcinoma sequence and its predicating significance in patients with sporadic colorectal cancer. Clinical Immunology. 183. 266–272. 19 indexed citations
4.
Goll, Rasmus, Johanna Hol Fosse, Trine Olsen, et al.. (2016). Loss of interleukin 33 expression in colonic crypts - a potential marker for disease remission in ulcerative colitis. Scientific Reports. 6(1). 35403–35403. 19 indexed citations
5.
Olsen, Trine, Eyvind J. Paulssen, Knut Johnsen, et al.. (2016). Normalization of mucosal tumor necrosis factor-α: A new criterion for discontinuing infliximab therapy in ulcerative colitis. Cytokine. 79. 90–95. 18 indexed citations
6.
Yang, Hang, Gang Xu, Jingli Ren, et al.. (2014). Therapeutic efficacy of IL-17A antibody injection in preventing the development of colitis associated carcinogenesis in mice. Immunobiology. 220(1). 54–59. 36 indexed citations
7.
Cui, Jing, et al.. (2013). The Role of Interleukin-17A in Colorectal Tumorigenesis. Cancer Biotherapy and Radiopharmaceuticals. 28(6). 429–432. 19 indexed citations
8.
Olsen, Trine, Guanglin Cui, Eyvind J. Paulssen, et al.. (2013). Normalization of mucosal cytokine gene expression levels predicts long-term remission after discontinuation of anti-TNF therapy in Crohn's disease. Scandinavian Journal of Gastroenterology. 48(3). 311–319. 44 indexed citations
9.
Olsen, Trine, et al.. (2012). The effect of adalimumab for induction of endoscopic healing and normalization of mucosal cytokine gene expression in Crohn's disease. Scandinavian Journal of Gastroenterology. 47(10). 1200–1210. 24 indexed citations
10.
Cui, Guanglin, et al.. (2012). Immune microenvironmental shift along human colorectal adenoma–carcinoma sequence: is it relevant to tumor development, biomarkers and biotherapeutic targets?. Scandinavian Journal of Gastroenterology. 47(4). 367–377. 25 indexed citations
11.
Asfeldt, Anne Mette, et al.. (2012). Prevalence, comorbidity, and risk factors for functional bowel symptoms: a population-based survey in Northern Norway. Scandinavian Journal of Gastroenterology. 47(11). 1274–1282. 27 indexed citations
12.
Daperno, Marco, Fabiana Castiglione, Lissy de Ridder, et al.. (2011). Results of the 2nd part Scientific Workshop of the ECCO (II): Measures and markers of prediction to achieve, detect, and monitor intestinal healing in Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 5(5). 484–498. 88 indexed citations
13.
Olsen, Trine, Rasmus Goll, Guanglin Cui, Ingrid Christiansen, & Jon Florholmen. (2009). TNF-alpha gene expression in colorectal mucosa as a predictor of remission after induction therapy with infliximab in ulcerative colitis. Cytokine. 46(2). 222–227. 66 indexed citations
14.
Cui, Guanglin, Aping Yuan, Rasmus Goll, Barthold Vonen, & Jon Florholmen. (2009). Dynamic changes of interleukin-8 network along the colorectal adenoma–carcinoma sequence. Cancer Immunology Immunotherapy. 58(11). 1897–1905. 37 indexed citations
15.
Asfeldt, Anne Mette, Sonja E. Steigen, Maja‐Lisa Løchen, et al.. (2009). The natural course of Helicobacter pylori infection on endoscopic findings in a population during 17 years of follow-up: the Sørreisa gastrointestinal disorder study. European Journal of Epidemiology. 24(10). 649–658. 24 indexed citations
16.
17.
Cui, Guanglin, Rasmus Goll, Trine Olsen, et al.. (2006). Reduced expression of microenvironmental Th1 cytokines accompanies adenomas–carcinomas sequence of colorectum. Cancer Immunology Immunotherapy. 56(7). 985–995. 57 indexed citations
18.
Birketvedt, Grethe Støa, K. J. Berg, O. Fausa, & Jon Florholmen. (2000). Glomerular and tubular renal functions after long-term medication of sulphasalazine, olsalazine, and mesalazine in patients with ulcerative colitis. Inflammatory Bowel Diseases. 6(4). 275–279. 24 indexed citations
19.
Florholmen, Jon, Sigurd Lindal, Ola Røkke, et al.. (1988). Effects of endotoxin on the pancreatic ultrastructure. Apmis. 96(7-12). 991–996. 8 indexed citations
20.
Haukland, Hanne H., Pål Øian, Jan Martin Maltau, Jon Florholmen, & P. G. Burhol. (1987). The effect of severe pre‐eclampsia on the pancreas: changes in the serum cationic trypsinogen and pancreatic amylase. BJOG An International Journal of Obstetrics & Gynaecology. 94(8). 765–767. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wu Zhen Dong Breakdown of academic impact, for papers by Xavier Tréton Breakdown of academic impact, for papers by Marjorie Argollo Breakdown of academic impact, for papers by Murat Törüner Breakdown of academic impact, for papers by Fabrizio Bossa Breakdown of academic impact, for papers by Jean Frédéric Colombel Breakdown of academic impact, for papers by Jan Däbritz Breakdown of academic impact, for papers by Steven M. Cohn Breakdown of academic impact, for papers by Colette Deslandres Breakdown of academic impact, for papers by Jakob Hendel
Rankless by CCL
2026